Search Results - "Weidemann, F."

Long‐term outcome of enzyme‐replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications by Weidemann, F., Niemann, M., Störk, S., Breunig, F., Beer, M., Sommer, C., Herrmann, S., Ertl, G., Wanner, C.

“…Objective The long‐term effects of enzyme‐replacement therapy (ERT) in Fabry disease are unknown. Thus, the aim of this study was to determine whether ERT in…”
Get full text

Longer-term recurrence rate after low versus high dose radioiodine ablation for differentiated thyroid Cancer in low and intermediate risk patients: a meta-analysis by Vardarli, I, Weidemann, F, Aboukoura, M, Herrmann, K, Binse, I, Görges, R

“…Regarding the longer-term recurrence rate the optimal activity for the remnant thyroid ablation in patients with differentiated thyroid cancer (DTC) is…”
Get full text

Clinical benefit of enzyme replacement therapy in Fabry disease by Breunig, F., Weidemann, F., Strotmann, J., Knoll, A., Wanner, C.

“…Enzyme replacement therapy (ERT) with recombinant human α-galactosidase A (r-hαGalA) enhances microvascular globotriaosylceramide clearance and improves…”
Get full text

Uncertain diagnosis of Fabry disease: Consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significance by Smid, B.E, van der Tol, L, Cecchi, F, Elliott, P.M, Hughes, D.A, Linthorst, G.E, Timmermans, J, Weidemann, F, West, M.L, Biegstraaten, M, Lekanne Deprez, R.H, Florquin, S, Postema, P.G, Tomberli, B, van der Wal, A.C, van den Bergh Weerman, M.A, Hollak, C.E

“…Abstract Background Screening in subjects with left ventricular hypertrophy (LVH) reveals a high prevalence of Fabry disease (FD). Often, a diagnosis is…”
Get full text

The dorsal tangent line – A new approach in the radiological analysis of metacarpal fractures by Winkelmann, M., Halacz, J.M., Weidemann, F., Gaulke, R.

“…Traditionally, the angle between the intersecting central axes (lateral projection intersecting central axes - LCA) of the proximal and distal fragments of…”
Get full text

Cardiac challenges in patients with Fabry disease by Weidemann, F, Linhart, A, Monserrat, L, Strotmann, J

“…Abstract Fabry disease, an X-linked lysosomal storage disorder affecting both men and women, is a relatively prevalent cause of hypertrophic cardiomyopathy…”
Get full text

Idebenone treatment in Friedreich's ataxia: Neurological, cardiac, and biochemical monitoring by BUYSE, G, MERTENS, L, DI SALVO, G, MATTHIJS, I, WEIDEMANN, F, EYSKENS, B, GOOSSENS, W, GOEMANS, N, SUTHERLAND, G. R, VAN HOVE, J. L. K

“…The authors report 1-year prospective data on eight patients with Friedreich ataxia. Idebenone did not halt the progression of ataxia. At the end of therapy,…”
Get full text

A dangerous combination: Fabry disease and factor V Leiden by Niemann, M., Weidemann, F.

Get full text

Echocardiography in diabetic cardiomyopathy by Niemann, M, Herrmann, S, Ertl, G, Weidemann, F

“…The term diabetic cardiomyopathy was initially introduced in the 1980s when evidence was found that diabetes leads to a distinct cardiomyopathy, independent of…”
Get full text

HMG CoA reductase inhibition and left ventricular mass in hypertrophic cardiomyopathy: a randomized placebo-controlled pilot study by Bauersachs, J., Störk, S., Kung, M., Waller, C., Fidler, F., Hoyer, C., Frantz, S., Weidemann, F., Ertl, G., Angermann, C. E.

“…Background  Statins reduce cardiomyocyte hypertrophy in animal models of hypertrophic cardiomyopathy, aortic banding and heart failure after myocardial…”
Get full text

Too Early or Too Late? Impact of Different Herpes Zoster Vaccine’s Waning Rates on Age-Specific Incremental Cost-Effectiveness Ratio by Ultsch, B, Weidemann, F, Reinhold, T, Siedler, A, Krause, G, Wichmann, O

Get full text

Myocardial lipid content in Fabry disease: a combined 1H-MR spectroscopy and MR imaging study at 3 Tesla by Petritsch, B, Köstler, H, Weng, A. M, Horn, M, Gassenmaier, T, Kunz, A. S, Weidemann, F, Wanner, C, Bley, T. A, Beer, M

“…Background Fabry disease is characterized by a progressive deposition of sphingolipids in different organ systems, whereby cardiac involvement leads to death…”
Get full text

Assessment of systolic function in patients with poor echogenicity: echocardiographic methods by Weidemann, F, Liu, D, Niemann, M, Herrmann, S, Hu, H, Gaudron, P D, Ertl, G, Hu, K

“…The visual echocardiographic evaluation of left ventricular (LV) systolic function can be cumbersome, especially in patients with poor image quality. This…”
Get full text

Cost-Effectiveness of Childhood Rotavirus Vaccination in Germany by Aidelsburger, P, Grabein, K, Boehm, K, Helbig, A.K, Dietl, M, Wasem, J, Koch, J, Ultsch, B, Weidemann, F, Wichmann, O

Get full text

Assessment of diastolic heart failure. Current role of echocardiography by Weidemann, F, Niemann, M, Herrmann, S, Ertl, G, Störk, S

“…Diastolic heart failure, also known as heart failure with preserved left ventricular ejection fraction (HF-pEF), is responsible for approximately 50 % of all…”
Get full text

P07—Ventricular Arrhythmias are the Major Cause of Death in Patients With the Classical Phenotype of Fabry Disease by Niemann, M, Hartmann, T, Beer, M, Emmert, A, Breunig, F, Ertl, G, Wanner, C, Weidemann, F

Get full text

P10—Comprehensive Assessment of Long-Term Enzyme Replacement Therapy in Fabry Disease: The 5-Year Data by Baumgärtner, E.K, Niemann, M, Emmert, A, Breunig, F, Strotmann, J, Beer, M, Sommer, C, Ertl, G, Wanner, C, Weidemann, F

Get full text

Right ventricular involvement in patients with Fabry's disease and the effect of enzyme replacement therapy by Wuest, W, Machann, W, Breunig, F, Weidemann, F, Koestler, H, Hahn, D, Wanner, C, Beer, M

“…According to echocardiography reports, Fabry cardiomyopathy not only affects the left ventricle (LV) but also the right ventricle (RV). Until now no MRI…”
Get more information

Methods for Health Economic Evaluations of Vaccines – Results from an International Expert-Workshop by Ultsch, B, Damm, O, Beutels, P, Bilcke, J, Brüggenjürgen, B, Gerber-Grote, A.U, Greiner, W, Hanquet, G, Harder, T, Hutubessy, R, Jit, M, Knol, M, Kuhlmann, A, von Kries, R, Levy-Bruhl, D, Perleth, M, Postma, M.J, Salo, H, Siebert, U, Wasem, J, Weidemann, F, Wichmann, O

Get full text

Low flow/low gradient aortic valve stenosis : clinical and diagnostic management by Herrmann, S, Niemann, M, Störk, S, Hu, K, Voelker, W, Ertl, G, Weidemann, F

“…Low gradient aortic stenoses (AS) represent a special challenge for physicians with respect to an exact diagnosis and optimal therapy. The difficulty lies in…”
Get full text